(Q41844631)

English

IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL

scientific article published on 8 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 October 2017

IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL (English)

1 reference

Europe PubMed Central

13 October 2017

1 reference

based on heuristic

inferred from title

5

object named as

Ulf de Faire

1 reference

Europe PubMed Central

13 October 2017

4

object named as

Max Vikström

1 reference

Europe PubMed Central

13 October 2017

author name string

Roland Fiskesund

1

1 reference

Europe PubMed Central

13 October 2017

Jun Su

2

1 reference

Europe PubMed Central

13 October 2017

Ivana Bulatovic

3

1 reference

Europe PubMed Central

13 October 2017

Johan Frostegård

6

1 reference

Europe PubMed Central

13 October 2017

publication date

8 January 2012

1 reference

Europe PubMed Central

13 October 2017

Results in Immunology

1 reference

Europe PubMed Central

13 October 2017

2

1 reference

Europe PubMed Central

13 October 2017

13-18

1 reference

Europe PubMed Central

13 October 2017

Progress and challenges in translating the biology of atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Periodontal diseases and cardiovascular events: meta-analysis of observational studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Oxidative modification of LDL: its pathological role in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Mechanisms and consequences of macrophage apoptosis in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Oxidation-specific epitopes are important targets of innate immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Role of lysophosphatidylcholine (LPC) in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

The role of natural antibodies in atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Evidence for a role of phospholipid oxidation products in atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Bioactive phospholipid oxidation products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Human IgG subclasses and their relation to carbohydrate antigen immunocompetence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Phosphorylcholine antibodies in pulmonary infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

6 June 2018

Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Natural antibodies against phosphorylcholine as potential protective factors in SLE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862347

18 August 2018

Autoantibodies to OxLDL are decreased in individuals with borderline hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/24371562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylcholine-targeting immunization reduces atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24371562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24371562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity for phosphorylcholine of six murine myeloma proteins reactive with Pneumococcus C polysaccharide and beta-lipoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/24371562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subpopulations of antibodies to phosphocholine in human serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/24371562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24371562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.RINIM.2012.01.001

1 reference

Europe PubMed Central

13 October 2017

release_3vkzmg52nbgdbfilux2oxd7bgu

1 reference

https://api.fatcat.wiki/v0/release/3vkzmg52nbgdbfilux2oxd7bgu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

13 October 2017

1 reference

Europe PubMed Central

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41844631&oldid=1841586195"